Bortezomid in association therapy in relapsed, refractory multiple myeloma: Experience of a single center

被引：0
|
作者：
Buquicchio, C. [1 ]
Iacobazzi, A. [1 ]
Tarantini, G. [1 ]
Ciuffreda, L. [1 ]
Desantis, G. [1 ]
Santorsola, D. [1 ]
Riezzo, A. [1 ]
机构：
[1] ASL Bat, UO Ematol, Trani, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：151 / 151
页数：1
相关论文
共 50 条
  • [1] Carfilzomib experience in relapsed/refractory multiple myeloma: a single-center experience
    Uysal, Ayse
    Akad Soyer, Nur
    Ozkan, Melda
    Sahin, Fahri
    Vural, Filiz
    Tobu, Mahmut
    Tombuloglu, Murat
    Saydam, Guray
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2018, 48 (01) : 80 - 83
  • [2] CARFILZOMIB TREATMENT IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: SINGLE CENTER EXPERIENCE
    Uysal, A.
    Ozkan, M. Comert
    Soyer, N. Akad
    Sahin, F.
    Vural, F.
    Tobu, M.
    Tombuloglu, M.
    Saydam, G.
    LEUKEMIA RESEARCH, 2016, 49 : S29 - S30
  • [3] Daratumumab for the Treatment of Relapsed/Refractory Multiple Myeloma: A Single Center Experience
    Jimenez-Zepeda, Victor
    Duggan, Peter
    Neri, Paola
    Luider, Joanne
    Tay, Jason
    Bahlis, Nizar J.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E67 - E68
  • [4] RELAPSED AND REFRACTORY MULTIPLE MYELOMA, EVOLUTION AND COMPLICATIONS SINGLE CENTER EXPERIENCE
    Ionita, I.
    Cheveresan, L.
    Iordache, M.
    Calamar, D.
    Ionita, C.
    Oros, D.
    Ionita, M.
    Ionita, H.
    HAEMATOLOGICA, 2016, 101 : 796 - 796
  • [5] Longterm Lenalidomide therapy in relapsed or refractory multiple myeloma patients - a single-center experience
    Denecke, B.
    Bross-Bach, U.
    Kanz, L.
    Weisel, K.
    ONKOLOGIE, 2010, 33 : 248 - 248
  • [6] Bortezomib in relapsed and refractory multiple myeloma patients.: Experience of a single center
    Calabrese, E.
    Gallucci, C.
    Federico, V
    Mohamad, A.
    Foa, R.
    Petrucci, M. T.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 151 - 151
  • [7] BENDAMUSTINE, LENALIDOMIDE AND DEXAMETHASONE (BLD) COMBINATION THERAPY IN RELAPSED AND REFRACTORY MULTIPLE MYELOMA: A SINGLE CENTER EXPERIENCE
    Ciuffreda, L.
    Diomede, D.
    Miccolis, R. M.
    De Santis, G.
    Buquicchio, C.
    Santeramo, T. M.
    Tarantini, G.
    HAEMATOLOGICA, 2016, 101 : 796 - 797
  • [8] Pomalidomide, Cyclophosphamide and Dexamethasone for Relapsed/Refractory Multiple Myeloma: A Retrospective Single Center Experience
    Garderet, Laurent
    Polge, Emmanuelle
    Gueye, Mor Seny
    Kellil, Chaima
    Ova, Jeanny Guelongo Okouango
    Beohou, Eric
    Labopin, Myriam
    Mohty, Mohamad
    BLOOD, 2015, 126 (23)
  • [9] POMALIDOMIDE IN RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM): EXPERIENCE CENTER
    Cuesta Garcia, A.
    HAEMATOLOGICA, 2015, 100 : 104 - 104
  • [10] Bortezomib and dexamethasone for Japanese patients with relapsed and refractory multiple myeloma: a single center experience
    Igarashi, Natsue
    Chou, Takaaki
    Hirose, Takayuki
    Imai, Yousuke
    Ishiguro, Takuro
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2010, 92 (03) : 518 - 523
12345